Healthcare
Amgen Inc.
AMGN$393.17-10.08%
Price is delayed.
Add to watchlist
About Amgen Inc.
Amgen is a biotechnology company that makes drugs for serious diseases including cancer, heart disease, and bone conditions. Their products include Enbrel, Repatha, and biosimilars. The company generates strong cash flow and returns money to shareholders through dividends and buybacks.
Loading chart...
Members only
Full research is for ConvictionStocks members
Members read the rest of this page. Where we have it for this company, that is:
- What each number means, in plain English, with the Wall Street name where the two differ.
- A plain-English summary of the company.
- How many analysts cover it, and the count behind each rating.
- Recent news, dated.
Get the free weekly market digest
The week's biggest movers, every Sunday. No spam.
Look up another company
Related Research
More Healthcare stocks to explore